| ［1］ |
Anhalt GJ, Kim SC, Stanley JR, et al. Paraneoplastic pemphigus. An autoimmune mucocutaneous disease associated with neoplasia［J］. N Engl J Med, 1990,323（25）:1729⁃1735. doi: 10.1056/NEJM199012203232503.
|
| ［2］ |
Nguyen VT, Ndoye A, Bassler KD, et al. Classification, clinical manifestations, and immunopathological mechanisms of the epithelial variant of paraneoplastic autoimmune multiorgan syndrome: a reappraisal of paraneoplastic pemphigus［J］. Arch Dermatol, 2001,137（2）:193⁃206.
|
| ［3］ |
Amber KT, Valdebran M, Grando SA. Paraneoplastic autoimmune multiorgan syndrome （PAMS）: Beyond the single phenotype of paraneoplastic pemphigus［J］. Autoimmun Rev, 2018,17（10）:1002⁃1010. doi: 10.1016/j.autrev.2018.04.008.
|
| ［4］ |
McNally MA, Vangipuram R, Campbell MT, et al. Paraneoplastic pemphigus manifesting in a patient treated with pembrolizumab for urothelial carcinoma［J］. JAAD Case Rep, 2021,10:82⁃84. doi: 10.1016/j.jdcr.2021.02.012.
|
| ［5］ |
Zou M, Zhan K, Zhang Y, et al. A systematic review of paraneoplastic pemphigus and paraneoplastic autoimmune multiorgan syndrome: Clinical features and prognostic factors［J］. J Am Acad Dermatol, 2025,92（2）:307⁃310. doi: 10.1016/j.jaad.2024.10.013.
|
| ［6］ |
Liu Q, Bu DF, Li D, et al. Genotyping of HLA⁃Ⅰ and HLA⁃Ⅱalleles in Chinese patients with paraneoplastic pemphigus［J］. Br J Dermatol, 2008,158（3）:587⁃591. doi: 10.1111/j.1365⁃2133.2007.08361.x.
|
| ［7］ |
Ouedraogo E, Gottlieb J, de Masson A, et al. Risk factors for death and survival in paraneoplastic pemphigus associated with hematologic malignancies in adults［J］. J Am Acad Dermatol, 2019,80（6）:1544⁃1549. doi: 10.1016/j.jaad.2018.03.043.
|
| ［8］ |
Czernik A, Camilleri M, Pittelkow MR, et al. Paraneoplastic autoimmune multiorgan syndrome: 20 years after［J］. Int J Dermatol, 2011,50（8）:905⁃914. doi: 10.1111/j.1365⁃4632. 2011.04868.x.
|
| ［9］ |
Wang L, Bu D, Yang Y, et al. Castleman's tumours and production of autoantibody in paraneoplastic pemphigus［J］. Lancet, 2004,363（9408）:525⁃531. doi: 10.1016/S0140⁃6736（04）15539⁃6.
|
| ［10］ |
Anderson HJ, Huang S, Lee JB. Paraneoplastic pemphigus/paraneoplastic autoimmune multiorgan syndrome: Part I. Clinical overview and pathophysiology［J］. J Am Acad Dermatol, 2024,91（1）:1⁃10. doi: 10.1016/j.jaad.2023.08.020.
|
| ［11］ |
Maruta CW, Miyamoto D, Aoki V, et al. Paraneoplastic pemphigus: a clinical, laboratorial, and therapeutic overview［J］. An Bras Dermatol, 2019,94（4）:388⁃398. doi: 10.1590/abd1806⁃4841.20199165.
|
| ［12］ |
Choi Y, Nam KH, Lee JB, et al. Retrospective analysis of 12 Korean patients with paraneoplastic pemphigus［J］. J Dermatol, 2012,39（12）:973⁃981. doi: 10.1111/j.1346⁃8138.2012.01655.x.
|
| ［13］ |
宫海军, 蓝育青, 王梅, 等. 副肿瘤性天疱疮致眼部病变的病例回顾分析［J］. 中国眼耳鼻喉科杂志, 2017,17（6）:392⁃394. doi: 10.14166/j.issn.1671⁃2420.2017.06.003.
|
| ［14］ |
Ohzono A, Sogame R, Li X, et al. Clinical and immunological findings in 104 cases of paraneoplastic pemphigus［J］. Br J Dermatol, 2015,173（6）:1447⁃1452. doi: 10.1111/bjd.14162.
|
| ［15］ |
李丽, 吴超, 苏飞, 等. 13例副肿瘤性天疱疮的临床特征分析［J］. 中国麻风皮肤病杂志, 2015,（7）:398⁃400.
|
| ［16］ |
Simmons BJ, Adams JA, Cho⁃Vega JH, et al. Paraneoplastic pemphigus with cicatricial nail involvement［J］. Cutis, 2020,106（4）:E4⁃E6. doi: 10.12788/cutis.0098.
|
| ［17］ |
左亚刚, 王宝玺, 马东来, 等. 副肿瘤性天疱疮患者的脱发机制［J］. 中国医学科学院学报, 2005,27（3）:354⁃356.
|
| ［18］ |
周娜, 彭琳一, 曾跃平, 等. 16例副肿瘤性天疱疮/副肿瘤性自身免疫多器官综合征临床资料的回顾性分析［J］. 癌症进展, 2014,（5）:492⁃497. doi: 10.11877/j.issn.1672⁃1535.2014.12.05.17.
|
| ［19］ |
Lehman VT, Barrick BJ, Pittelkow MR, et al. Diagnostic imaging in paraneoplastic autoimmune multiorgan syndrome: retrospective single site study and literature review of 225 patients［J］. Int J Dermatol, 2015,54（4）:424⁃437. doi: 10.1111/ijd.12603.
|
| ［20］ |
Irrera M, Bozzola E, Cardoni A, et al. Paraneoplastic pemphigus and Castleman's disease: a case report and a revision of the literature［J］. Ital J Pediatr, 2023,49（1）:33. doi: 10.1186/s13052⁃023⁃01442⁃7.
|
| ［21］ |
Kaplan I, Hodak E, Ackerman L, et al. Neoplasms associated with paraneoplastic pemphigus: a review with emphasis on non⁃hematologic malignancy and oral mucosal manifestations［J］. Oral Oncol, 2004,40（6）:553⁃562. doi: 10.1016/j.oraloncology. 2003.09.020.
|
| ［22］ |
Antiga E, Bech R, Maglie R, et al. S2k guidelines on the management of paraneoplastic pemphigus/paraneoplastic autoimmune multiorgan syndrome initiated by the European Academy of Dermatology and Venereology （EADV）［J］. J Eur Acad Dermatol Venereol, 2023,37（6）:1118⁃1134. doi: 10.1111/jdv.18931.
|
| ［23］ |
张弘, 娜地拉·阿布里孜, 彭敏, 等. 闭塞性细支气管炎16例临床分析［J］. 中国呼吸与危重监护杂志, 2019,18（3）:241⁃246. doi: 10.7507/1671⁃6205.201808049.
|
| ［24］ |
Wang R, Li J, Wang M, et al. Prevalence of myasthenia gravis and associated autoantibodies in paraneoplastic pemphigus and their correlations with symptoms and prognosis［J］. Br J Dermatol, 2015,172（4）:968⁃975. doi: 10.1111/bjd.13525.
|
| ［25］ |
Samadi M, Najafi A, Naziriyan A, et al. Indirect immunofluorescence on rat bladder epithelium in patients with pemphigus vulgaris with an extended follow⁃up［J］. Skin Health Dis, 2022,2（3）:e142. doi: 10.1002/ski2.142.
|
| ［26］ |
Poot AM, Diercks GF, Kramer D, et al. Laboratory diagnosis of paraneoplastic pemphigus［J］. Br J Dermatol, 2013,169（5）:1016⁃1024. doi: 10.1111/bjd.12479.
|
| ［27］ |
Numata S, Teye K, Tsuruta D, et al. Anti⁃α⁃2⁃macroglobulin⁃like⁃1 autoantibodies are detected frequently and may be pathogenic in paraneoplastic pemphigus［J］. J Invest Dermatol, 2013,133（7）:1785⁃1793. doi: 10.1038/jid.2013.65.
|
| ［28］ |
Tsuchisaka A, Numata S, Teye K, et al. Epiplakin is a paraneoplastic pemphigus autoantigen and related to bronchiolitis obliterans in Japanese patients［J］. J Invest Dermatol, 2016,136（2）:399⁃408. doi: 10.1038/JID.2015.408.
|
| ［29］ |
Camisa C, Helm TN. Paraneoplastic pemphigus is a distinct neoplasia⁃induced autoimmune disease［J］. Arch Dermatol, 1993,129（7）:883⁃886.
|
| ［30］ |
Kwatra SG, Boozalis E, Pasieka H, et al. Decreased recognition of paraneoplastic pemphigus in patients previously treated with anti⁃CD 20 monoclonal antibodies［J］. Br J Dermatol, 2019,180（5）:1238⁃1239. doi: 10.1111/bjd.17577.
|
| ［31］ |
中国医师协会皮肤科医师分会, 中华医学会皮肤性病学分会治疗学组, 中国医疗保健国际交流促进会皮肤医学分会, 等. 中国天疱疮诊疗指南（2024版）［J］. 中华皮肤科杂志, 2024,57（10）:873⁃886. doi: 10.35541/cjd.20240222.
|
| ［32］ |
Frew JW, Murrell DF. Current management strategies in paraneoplastic pemphigus （paraneoplastic autoimmune multiorgan syndrome）［J］. Dermatol Clin, 2011,29（4）:607⁃612. doi: 10. 1016/j.det.2011.06.016.
|
| ［33］ |
Nanda M, Nanda A, Al⁃Sabah H, et al. Paraneoplastic pemphigus in association with B⁃cell lymphocytic leukemia and hepatitis C: favorable response to intravenous immunoglobulins and prednisolone［J］. Int J Dermatol, 2007,46（7）:767⁃769. doi: 10.1111/j.1365⁃4632.2007.03225.x.
|
| ［34］ |
中国医师协会皮肤科医师分会, 疑难重症及罕见病国家重点实验室, 国家皮肤与免疫疾病临床医学研究中心. 天疱疮患者健康教育共识（2023版）［J］. 中华皮肤科杂志, 2023,e20230123. doi:10.35541/cjd.20230123.
|
| ［35］ |
中华医学会麻醉学分会. 肾上腺糖皮质激素围手术期应用专家共识（2017版）［J］. 临床麻醉学杂志, 2017,33（7）:712⁃716.
|
| ［36］ |
Zhu X, Zhang B. Paraneoplastic pemphigus［J］. J Dermatol, 2007,34（8）:503⁃511. doi: 10.1111/j.1346⁃8138.2007.00322.x.
|
| ［37］ |
张燕, 潘萌. 副肿瘤性天疱疮11例分析［J］. 中华皮肤科杂志, 2014,47（10）:715⁃718. doi: 10.3760/cma.j.issn.0412⁃4030. 2014.10.009.
|
| ［38］ |
Cao L, Wang F, Du XY, et al. Chronic lymphocytic leukemia⁃associated paraneoplastic pemphigus: potential cause and therapeutic strategies［J］. Sci Rep, 2020,10（1）:16357. doi: 10. 1038/s41598⁃020⁃73131⁃y.
|
| ［39］ |
中国医师协会血液科医师分会, 中华医学会血液学分会. 造血干细胞移植后闭塞性细支气管炎综合征诊断与治疗中国专家共识（2022年版）［J］. 中华血液学杂志, 2022,43（6）:441⁃447. doi: 10.3760/cma.j.issn.0253⁃2727.2022.06.001.
|
| ［40］ |
Chen W, Zhao L, Guo L, et al. Clinical and pathological features of bronchiolitis obliterans requiring lung transplantation in paraneoplastic pemphigus associated with Castleman disease［J］. Clin Respir J, 2022,16（3）:173⁃181. doi: 10.1111/crj.13465.
|
| ［41］ |
曹淼, 崇杉, 胡新媛, 等. 副肿瘤性天疱疮患者原发肿瘤切除后皮肤黏膜感染及管理分析［J］. 中华皮肤科杂志, 2022,55（8）:669⁃675. doi: 10.35541/cjd.20220003.
|
| ［42］ |
Kishi T, Nakata J, Yamada T, et al. Fatal progression of bronchiolitis obliterans in spite of complete remission of follicular lymphoma and paraneoplastic pemphigus［J］. Ann Hematol, 2022,101（2）:453⁃455. doi: 10.1007/s00277⁃021⁃04499⁃8.
|
| ［43］ |
Kim JH, Kim SC. Paraneoplastic pemphigus: paraneoplastic autoimmune disease of the skin and mucosa［J］. Front Immunol, 2019,10:1259. doi: 10.3389/fimmu.2019.01259.
|
